ELEV insider buying & filings

ELEVElevation Oncology, Inc.

—

4 insider filings on record.
None of them an open-market buy in the last year.

Last Form 4 Jul 24 · scanned 7m ago

No price data yet — the yfinance scanner hasn't produced bars for ELEV.

AI brief · from the filings on this pagePro

The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.

Short % float

Pro

The record

newest first

DateTypeInsiderOf stakeShares @ priceValue

Jul 24OTHERFurlong TammyCHIEF FINANCIAL OFFICERdirect37,957 @ $0.3600$13.7K

Jul 24OTHERClackson Timothy PDirectorindirect47,330 @ $0.3600$17.0K

Jun 18TAXFerra Joseph J JrCHIEF EXECUTIVE OFFICERdirect4,627 @ $0.3854$1.8K

Jun 18EXERCISEFerra Joseph J JrCHIEF EXECUTIVE OFFICERdirect12,560 sh—

The file stays open

▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice